Leatt (OTCMKTS:LEAT) Issues Earnings Results

Leatt (OTCMKTS:LEAT) posted its quarterly earnings results on Tuesday. The company reported $0.08 earnings per share for the quarter, Zacks reports. Leatt had a net margin of 4.12% and a return on equity of 5.87%.

Here are the key takeaways from Leatt’s conference call:

• Revenue grew 41% to $61.91 million in 2025 with Q4 sales of $16.0 million (up ~43% YoY), marking consecutive quarters of double-digit growth driven by international demand and distributor restocking.
• Profitability improved materially—full-year net income was $3.26 million (up 248%) and gross margin rose to 44% (Q4 gross margin 46%), turning prior-year losses into quarterly and annual profits.
• Broad-based product momentum: helmets +59%, body armor +29% (footwear +40%), neck braces +18% and other parts/accessories +56%, with body armor representing 47% of 2025 revenues.
• Management plans to expand its global sales and marketing team and expects working capital and operating costs to rise (up 12%), while flagging tariff/geopolitical uncertainty—company reports $13.23 million in cash and an extended $750k buyback to support liquidity.

Leatt Trading Up 5.9%

OTCMKTS LEAT opened at $9.21 on Wednesday. The firm has a market cap of $57.38 million, a PE ratio of 25.58 and a beta of 0.92. Leatt has a 1-year low of $5.01 and a 1-year high of $14.50. The stock has a 50-day moving average of $9.09 and a 200-day moving average of $10.18.

Leatt Company Profile

Leatt (OTCMKTS:LEAT) is a designer and manufacturer of protective sports gear, specializing in advanced safety equipment for high-impact activities such as motocross, mountain biking, and snow sports. The company’s product portfolio includes the patented Leatt Brace® neck protection system, impact-absorbing body armor, full-face and off-road helmets, goggles, gloves, and riding apparel. These offerings are engineered to mitigate the risk of spinal and head injuries, combining biomechanical research with lightweight materials and user-focused design.

Founded by Dr.